Viewing Study NCT05125016


Ignite Creation Date: 2025-12-26 @ 11:46 AM
Ignite Modification Date: 2026-02-25 @ 6:44 PM
Study NCT ID: NCT05125016
Status: RECRUITING
Last Update Posted: 2025-04-09
First Post: 2021-10-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With Cemiplimab or REGN5678 for Adult Participants With Advanced Prostate Cancer
Sponsor: Regeneron Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Castration-resistant Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Treatment-experienced metastatic castration-resistant prostate cancer (mCRPC) View